Products
Pimobendan is approved for animals in the form of capsules, injectable solution, and chewable tablets. It has been approved in many countries since 1998.
Structure and properties
Pimobendan (C19H18N4O2, Mr = 334.4 g/mol) is a benzimidazole pyridazinone derivative.
Effects
Pimobendan (ATCvet QC01CE90) has vasodilator properties. The effects are due to inhibition of phosphodiesterase type II and type III.
Indications
For the treatment of myocardial insufficiency in dogs.